N/A
Completed N=798
Communicating Risk Information for Obesity
Source: ClinicalTrials.gov NCT01355224 ↗Enrolled (actual)
798
Serious AEs
0.0%
Results posted
Mar 2017
Primary outcomePrimary: Intentions to Lose Weight - Effect of Study Arm on Outcomes — 3.06; 3.37; 3.26; 3.26 units on a scale — p=.0150
Summary
This study will examine the impact of providing genetic risk information for obesity on people's attitudes and beliefs about obesity, health behaviors and weight outcomes. Specifically, this study will examine the feasibility of using genetic information to motivate efforts to reduce obesity among individuals recruited to the Coriell Personalized Medicine Collaborative (CPMC), see below for description of CPMC.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Intentions to Lose Weight - Effect of Study Arm on Outcomes |
3.06; 3.37; 3.26; 3.26 | .0150 sig |
| PRIMARY Intention to Lose Weight - Impact of Risk Status |
3.05; 3.38; 3.35; 3.38; 3.19 | 0.0365 sig |
| PRIMARY Intention to Lose Weight - Combined Risk |
3.08; 3.38; 3.12; 3.24; 3.37 | 0.0622 |
Eligibility Criteria
Inclusion Criteria
Must be age 18 or older, active enrollees in the CPMC trial, and able to read and write in English.
Exclusion Criteria
Individuals that do not meet the inclusion criteria.
Data sourced from ClinicalTrials.gov (NCT01355224). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.